Pancreatic Cancer Research

ResearcherTexas A&M UniversityActive in the last 2 years

Mehrdad Zarei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0127-1489; OpenAlex author ID A5010055867. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2021: 1 paper · 2022: 4 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 3 papers

Papers 10

  1. Vitamin B3 derivatives support pancreatic cancer cell survival and chemotherapy resistance. First author DOI 10.1016/j.canlet.2026.218334↗
  2. A ketogenic diet sensitizes pancreatic cancer to glutamine metabolism inhibitors. Co-author DOI 10.1016/j.xcrm.2026.102770↗
  3. Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies. First author DOI 10.1158/2767-9764.crc-25-0338↗
  4. IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-23-1895↗
  5. Increased glucose availability sensitizes pancreatic cancer to chemotherapy. Co-author DOI 10.1038/s41467-023-38921-8↗
  6. Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer. Co-author DOI 10.1002/pon.5945↗
  7. Surgical techniques and tips for a reliable murine model of primary and metastatic pancreatic cancer First author DOI 10.1101/2022.07.30.502136↗
  8. IDO1 Is a Therapeutic Target for Pancreatic Cancer-Associated Depression. Co-author DOI 10.1158/1535-7163.mct-22-0055↗
  9. Liver Endothelium Microenvironment Promotes HER3-mediated Cell Growth in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.26502/jcsct.5079182↗
  10. Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2767-9764.crc-21-0073↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jordan Michael Winter · 9 shared papers, 2022–2026 · strength 1.64
  2. Ali Vaziri Gohar · 9 shared papers, 2021–2026 · strength 1.46
  3. Omid Hajihassani · 8 shared papers, 2022–2026 · strength 1.33
  4. Jonathan J. Hue · 7 shared papers, 2022–2026 · strength 1.19
  5. Erryk Katayama · 4 shared papers, 2022–2026 · strength 0.69
  6. Jonathan Robert Brody · 4 shared papers, 2022–2026 · strength 0.69
  7. Luke Daniel Rothermel · 3 shared papers, 2022–2026 · strength 0.51
  8. Faith Nakazzi · 2 shared papers, 2024–2026 · strength 0.48
  9. Moeez Ghani Rathore · 3 shared papers, 2022–2026 · strength 0.47
  10. Rui Wang · 2 shared papers, 2022–2023 · strength 0.27
  11. Mahsa Zarei · 2 shared papers, 2021–2023 · strength 0.25
  12. Lisa M. Coussens · 1 shared paper, 2026 · strength 0.23
  13. Katie E. Blise · 1 shared paper, 2026 · strength 0.23
  14. Sami O. Abul-Khoudoud · 1 shared paper, 2026 · strength 0.23
  15. Robert L Eil · 1 shared paper, 2026 · strength 0.23
  16. Rosalie C. Sears · 1 shared paper, 2026 · strength 0.23
  17. Charles D. Lopez · 1 shared paper, 2026 · strength 0.23
  18. Joshua D. Rabinowitz · 1 shared paper, 2026 · strength 0.19
  19. Akram S. Shalaby · 1 shared paper, 2024 · strength 0.18
  20. Wei Zhang · 1 shared paper, 2022 · strength 0.15
  21. Mohamedraed Elshami · 1 shared paper, 2022 · strength 0.13
  22. Nathaniel E Davis · 1 shared paper, 2022 · strength 0.13
  23. Li Zhang · 1 shared paper, 2023 · strength 0.13
  24. Costas Andreas Lyssiotis · 1 shared paper, 2023 · strength 0.13
  25. Sneha H. Johnson · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.